Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary

Gynecologic Oncology

Volumn 68, Issue 1, 1998, Pages 35-37

  Suzuki, Mitsuaki ^a   Kobayashi, Hiroshi ^b   Ohwada, Michitaka ^a   Terao, Toshihiko ^b   Sato, Ikuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CA125; Dysgerminoma; Germ cell; Macrophage colony stimulating factor; Tumor marker; Tumors of the ovary

Indexed keywords

CA 125 ANTIGEN; MACROPHAGE ACTIVATING FACTOR; TUMOR MARKER;

ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYSGERMINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERM CELL TUMOR; HUMAN; OVARY TUMOR; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0031932284     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4897     Document Type: Article

References (14)

1. Suzuki M, Ohwada M, Aida I, Tamada T, Hanamura T, Nagatomo M. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer. Obstet Gynecol. 82:1993;946-950.
2. Suzuki M, Ohwada M, Sato I, Nagatomo M. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies. Oncology. 52:1995;128-133.
3. Kawai M, Kano T, Kikkawa F, Morikawa Y, Oguchi H, Nakashima N, Ishizuka T, Kuzuya K, Ohta M, Arii Y, Tomoda Y. Seven tumor markers in benign and malignant germ cell tumors of the ovary. Gynecol Oncol. 45:1992;248-253.
4. Hanamura T, Motoyoshi K, Yoshida K, Saito M, Miura Y, Kawashima T, Nishida M, Takaku F. Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood. 72:1988;886-892.
5. Bast R C, Klug T L, John E RN, Jenison E, Niloff J M, Lazarus H, Berkowitz R S, Leavitt T, Griffiths T, Parker L, Zurawski V R, Knapp R C. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 309:1983;883-887.
6. Sakurabayashi I, Kawai T, Suzuki M, Tamada T, Sato K, Yonezawa M. Clinical evaluation of a cancer antigen, CA125, associated with ovarian cancer. I. Technical investigation and the reference value. Rinsho Byori. 32:1984;1345-1349.
7. Fujii S, Konishi I, Suzuki A, Okamura H, Okazaki T, Mori T. Analysis of serum lactic dehydrogenase levels and its isoenzymes in ovarian dysgerminoma. Gynecol Oncol. 22:1985;65-72.
8. Schwartz P E, Morris J M. Serum lactic dehydrogenase: A tumor marker for dysgerminoma. Obstet Gynecol. 72:1988;511-515.
9. Talerman A, Haije W G, Baggerman L. Serum alphafetoprotein (AFP) in diagnosis and management of endodermal sinus (yolk sac) tumor and mixed germ cell tumor of the ovary. Cancer. 41:1978;272-278.
10. Talerman A, Haije W G, Baggerman L. Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites. Cancer. 46:1980;380-385.
11. Suzuki M, Kobayashi H, Sekiguchi I, Konnai K, Terao T, Sato I. Clinical evaluation of squamous cell carcinoma antigen in squamous cell carcinoma arising in mature cystic teratoma of the ovary. Oncology. 52:1995;287-290.
12. Pittaway D E, Fayez J A. The use of CA125 in the diagnosis and management of endometriosis. Fertil Steril. 46:1986;790-795.
13. Kuzuya K, Nozaki M, Chihara T. Evaluation of CA125 as a circulating tumor marker for ovarian cancer. Nippon Sanka Fujinka Gakkai Zasshi. 38:1986;949-957.
14. Vasilev S A, Schlaerth J B, Campeau J, Morrow C P. Serum CA125 levels in preoperative evaluation of pelvic masses. Obstet Gynecol. 71:1988;751-756.